| Industry | 制造业 | ||||||||||||||||||||||||
| Company Introduction | 北京中关村科技发展(控股)股份有限公司（简称中关村科技），1999年成立并在深交所挂牌上市。2015年，中关村科技的产业格局逐步从“科技地产+医药”，转型至以“医药大健康”为核心的发展经营战略。2018年8月，中关村科技得到监管部门的认可，所属行业分类由“综合”变更为“医药制造业”，战略转型初步成功。2021年8月，公司调整发展战略，进一步聚焦定位，拟建立专注医药领域的创新型医药产业集团。 通过近几年的高速发展，中关村科技已在医药、健康、养老、投资四大板块拥有十多家理念先进、管理规范、产品过硬、极具行业竞争力的高品质企业。 未来，中关村科技将以创新为驱动，以政策和需求为导向，整合内外部资源，以现有医药业务为基础，通过激活沉淀品种、产品线自研扩充，构建原料药到制剂一体化的有竞争力的生产模式，稳步提升现有业务规模，强化在心血管、口腔、消化、妇科和麻精等多个领域的市场竞争力。同时，积极探索生物制药新领域，全力推动创新型药物的发展，打造多个产品集群，更进一步地提升市场竞争力，最终成为创新型医药产业集团。 | ||||||||||||||||||||||||
| Main Business | 生物医药、医疗器械、个人护理用品、养老服务业务和其他业务 | ||||||||||||||||||||||||
| Legal Representative | 许钟民 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | 黄志宇 | ||||||||||||||||||||||||
| Solicitors | 北京观韬中茂律师事务所 | ||||||||||||||||||||||||
| Auditors | 致同会计师事务所(特殊普通合伙);中兴华会计师事务所（特殊普通合伙） | ||||||||||||||||||||||||
| Tel No | 010-57768018 | ||||||||||||||||||||||||
| Fax No | 010-57768100 | ||||||||||||||||||||||||
| Website | www.centek.com.cn | ||||||||||||||||||||||||
| investor@centek.com.cn | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 12/07/1999 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ 0.065 | ||||||||||||||||||||||||
| DPS(RMB)* | -- | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 2.038 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 3.619B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |